IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells

Jennifer L Spencer Clinton1, Linda L Tran2,3, Megan B Vogt2

  • 1Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America.

Plos One
|December 30, 2020
PubMed

Insights

Zika virus (ZIKV) exhibits varied immune responses in prostate cells based on strain and passage history. Targeting the IP-10/CXCR3 pathway shows potential for preventing sexual transmission of ZIKV.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Zika virus (ZIKV) replicates in human prostate cells, indicating the prostate as a potential viral reservoir.
  • Innate immune responses to ZIKV strains vary significantly based on their passage history in different host cells.

Purpose of the Study:

  • To investigate the differential innate immune responses to distinct ZIKV strains in human prostate cells.
  • To determine the role of IP-10 and its receptor CXCR3 in ZIKV replication and gene expression within prostate cells.
  • To explore the potential of targeting the IP-10/CXCR3 pathway for therapeutic intervention against ZIKV sexual transmission.

Main Methods:

  • Analysis of innate immune responses (IP-10, IFNγ) to three ZIKV strains with varying passage histories in human prostate epithelial and stromal mesenchymal stem cells.
  • Assessment of ZIKV RNA and virus production following treatment with IP-10, CXCR3 agonist, or CXCR3 antagonist.
  • Evaluation of CXCR3 isoform (CXCR3-A, CXCR3-B) gene expression in response to ZIKV infection.
  • Examination of the effects of IP-10, agonist, or antagonist on cell death and proliferation.

Main Results:

  • Significant differences in innate immune responses were observed among ZIKV strains, influenced by passage history, with some differences diminishing after additional cell culture passages.
  • Two ZIKV strains induced high levels of IP-10 and IFNγ in prostate cells.
  • IP-10 and CXCR3 signaling modulation significantly altered ZIKV gene expression, with effects dependent on viral passage history.
  • Differential expression of CXCR3-A and CXCR3-B isoforms was detected in prostate cell types, potentially explaining variations in viral output.
  • No significant impact of IP-10 or CXCR3 modulation on cell death or proliferation was observed at relevant infection rates.

Conclusions:

  • ZIKV strain phenotype and replication dynamics are heavily influenced by passage history, underscoring the importance of using viruses with minimal passage for research.
  • The IP-10/CXCR3 signaling axis plays a crucial role in modulating ZIKV replication and gene expression in prostate cells.
  • CXCR3 signaling represents a promising therapeutic target to inhibit ZIKV replication and prevent sexual transmission.